Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
24.7M
-
Shares change
-
-316K
-
Total reported value, excl. options
-
$340M
-
Value change
-
-$4.32M
-
Number of buys
-
35
-
Number of sells
-
-45
-
Price
-
$13.80
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2016
99 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2016.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7M shares
of 37.4M outstanding shares and own 65.89% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (3.02M shares), FRANKLIN RESOURCES INC (2.85M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.29M shares), VANGUARD GROUP INC (1.21M shares), ROYCE & ASSOCIATES LP (977K shares), HEARTLAND ADVISORS INC (970K shares), ROYAL BANK OF CANADA (922K shares), THOMSON HORSTMANN & BRYANT INC (897K shares), and BlackRock Fund Advisors (876K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.